Home Newsfeeds Morgan Stanley Maintains Equal-Weight on Principal Finl Gr, Raises Price Target to $70

Morgan Stanley Maintains Equal-Weight on Principal Finl Gr, Raises Price Target to $70

Morgan Stanley analyst Nigel Dally maintains Principal Finl Gr (NASDAQ:PFG) with a Equal-Weight and raises the price target from $68 to $70.

byBenzinga Newsdesk

August 17, 2022

1 minute read

Morgan Stanley analyst Nigel Dally maintains Principal Finl Gr (NASDAQ:PFG) with a Equal-Weight and raises the price target from $68 to $70.

Why UP Fintech Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket

By Lisa Levin

November 27, 9:10 AM

Shares of UP Fintech Holding Limited (NASDAQ: TIGR) surged in pre-market trading after the company results for the third quarter.

AGRI

Roche To Introduce Next-Generation Portfolio Of COVID-19 Rapid Tests

By Vandana Singh

October 12, 6:53 AM

Roche Holdings AG (OTC:RHHBY) has announced the launch of its next-generation portfolio of COVID-19 rapid antigen tests (2.0) for self-testing and…

RHHBF

EXCLUSIVE: AMA Moves Toward Psychedelic Therapy Reimbursement, ‘Filing A Gap’ In Regulations

By Lara Goldstein

May 2, 7:00 AM

The American Medical Association (AMA) is expected to issue the first code for psychedelic therapy reimbursement, following Tuesday's approval of a joint application submitted by MAPS PBC and COMPASS Pathways (NASDAQ: CMPS).

CMPS

FingerMotion Retires Convertible Debt Totaling Over $5M, Eliminating all Institutional Loans

By Happy Mohamed

April 12, 9:08 AM

FingerMotion, Inc. (NASDAQ:FNGR) (the "Company" or "FingerMotion"), a mobile data and services company, today reported that the Company has recently eliminated its remaining convertible debt with the

FNGR

Morgan Stanley Maintains Equal-Weight on Principal Finl Gr, Raises Price Target to $70

Related Posts

Why UP Fintech Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket

Roche To Introduce Next-Generation Portfolio Of COVID-19 Rapid Tests

EXCLUSIVE: AMA Moves Toward Psychedelic Therapy Reimbursement, ‘Filing A Gap’ In Regulations

FingerMotion Retires Convertible Debt Totaling Over $5M, Eliminating all Institutional Loans